Immunovant, Inc. (IMVT)
35.55
+9.26
(+35.22%)
USD |
NASDAQ |
May 20, 16:00
35.91
+0.36
(+1.01%)
After-Hours: 06:33
Immunovant Total Assets (Quarterly) : 1.052B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 19.92M |
| Perspective Therapeutics, Inc. | 410.77M |
| AVITA Medical, Inc. | 51.54M |
| Viridian Therapeutics, Inc. | 789.02M |
| Twist Bioscience Corp. | 676.21M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.26M |
| Shareholders Equity (Quarterly) | 986.14M |
| Current Ratio | 15.74 |
| Net Debt Paydown Yield | 0.00% |